Future studies integrating transcriptomic and proteomic data will further clarify the therapeutic potential of the FGF21 pathway in seipin-related disorders as continuous refinement and thorough characterization of these animal models will be pivotal in bridging the gap between murine and human manifestations of these rare genetic disorders. Here, FGF21 is linked to hereditary disease.